Last-Minute Thought: Scotiabank Weighs In on Oracle Stock Ahead of Earnings Today

Oracle reports fiscal Q3 after the close; shares sit 57% below last September’s peak and Scotiabank’s Patrick Colville retains an Outperform while trimming his price target to $215 (from $220). Colville cites a $25B debt issuance, a planned ~$25B equity offering (and ~ $20B share issuance in FY26) as removing overhangs, but expects EPS to be ~2% and ~8% below Street for F3Q and F4Q due to higher interest expense; he also notes OpenAI funding (covering ~60% of Oracle's RPO) and potential Meta capacity as positives. He argues roughly $25B of capex drives ~$10B of annual revenue, points to ~$35B spent over the past four quarters and similar planned capex over the next two quarters to support an OCI revenue ramp; consensus remains a Strong Buy with an average price target of $260.28 (~72% one-year upside).

Analysis

Oracle’s capital-intense push creates a two-track competitive dynamic: upside if utilization and enterprise migration accelerate, and downside if the revenue ramp lags the fixed-cost base. The critical lever is utilization velocity — marginal revenue per incremental rack will determine whether ROIC moves toward technology peers or stays anchored near legacy software multiples. Expect hardware OEMs, colo operators and networking vendors to see demand asymmetry: they get near-term benefit from buildouts while Oracle carries the long-tail cashflow and execution risk.

Near-term market sensitivity centers on three timed drivers: the earnings print (days), guidance and balance-sheet disclosures (weeks), and actual customer onboarding/consumption trends (quarters). Financing and equity overhangs compress EPS volatility and increase equity’s beta versus fundamentals; credit-market repricing or visible demand acceleration are the plausible catalysts to re-rate the equity. Tail risks are execution slippage on large deals, an enterprise pause in AI spend, or a broader tech funding shock that raises cost of capital and forces deeper dilution.

Contrarian read: the market may be over-penalizing headline-level spend without crediting how quickly AI consumption converts to sticky recurring revenue once SLAs, migration tooling and partner ecosystem scale. That implies asymmetric payoff for patient, time‑arbitrage capital willing to underwrite near-term EPS noise for multi-quarter monetization. However, the cleaner arbitrage is option-structured or pair positions that capture re-rating without overexposure to potential dilution or higher interest cost shocks.

Key Decisions for Investors

• Event-driven equity: Buy ORCL on a post-earnings pullback sized 1–1.5% NAV, target 40%+ total return over 9–12 months, hard stop at 20% loss; rationale: capture re-rating if consumption commentary and net-new customer metrics show acceleration while limiting headline-driven entry risk.
• Asymmetric options: Purchase ORCL Jan-2027 25% OTM LEAP calls (~18–24 month tenor) sized 0.5% NAV for high convexity, financed by selling 2–3 month 10% OTM calls in small size to reduce carry; thesis: long-dated upside if monetization accelerates, while short-term call sales monetize premium ahead of potential guidance noise.
• Relative-value pair: Long ORCL / short an overvalued pure-software multiple (e.g., ticker SNOW) in equal notional exposure for 6–12 months to isolate data-center monetization vs valuation multiple compression; target convergence of 20–30% relative outperformance with a stop if the pair moves against by 15%.
• Credit-driven trade: Buy ORCL senior bonds with 2–5 year maturities on any material selloff, targeting running yield pickup vs IG index and potential spread tightening if revenue cadence proves sticky; size modestly (0.5–1% NAV) given balance-sheet leverage uncertainty.